Clinical Trial Update: Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of thrombopoietin in patients with severe and very severe aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Very Severe Aplastic Anemia

Drugs mentioned

• Thrombopoietin (thrombopoietin)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Anemia, Aplastic | Phase 2 | Status: UNKNOWN